These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12871685)

  • 1. LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study.
    Cotter G; Kaluski E; Milo O; Blatt A; Salah A; Hendler A; Krakover R; Golick A; Vered Z
    Eur Heart J; 2003 Jul; 24(14):1287-95. PubMed ID: 12871685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthase inhibitors in post-myocardial infarction cardiogenic shock--an update.
    Kaluski E; Hendler A; Blatt A; Uriel N
    Clin Cardiol; 2006 Nov; 29(11):482-8. PubMed ID: 17133844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiogenic shock: have we really found the magic potion?
    Menon V
    Eur Heart J; 2003 Jul; 24(14):1279-81. PubMed ID: 12871682
    [No Abstract]   [Full Text] [Related]  

  • 4. L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock.
    Cotter G; Kaluski E; Blatt A; Milovanov O; Moshkovitz Y; Zaidenstein R; Salah A; Alon D; Michovitz Y; Metzger M; Vered Z; Golik A
    Circulation; 2000 Mar; 101(12):1358-61. PubMed ID: 10736276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
    ; Alexander JH; Reynolds HR; Stebbins AL; Dzavik V; Harrington RA; Van de Werf F; Hochman JS
    JAMA; 2007 Apr; 297(15):1657-66. PubMed ID: 17387132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiogenic shock: basics and clinical considerations.
    Gowda RM; Fox JT; Khan IA
    Int J Cardiol; 2008 Jan; 123(3):221-8. PubMed ID: 18037513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-aortic balloon pump combined with mechanical ventilation for treating patients aged > 60 years in cardiogenic shock: Retrospective analysis.
    Liu H; Wu X; Zhao X; Zhu P; Han L
    J Int Med Res; 2016 Jun; 44(3):433-43. PubMed ID: 27020597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
    Prondzinsky R; Lemm H; Swyter M; Wegener N; Unverzagt S; Carter JM; Russ M; Schlitt A; Buerke U; Christoph A; Schmidt H; Winkler M; Thiery J; Werdan K; Buerke M
    Crit Care Med; 2010 Jan; 38(1):152-60. PubMed ID: 19770739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
    Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
    J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.
    Ouweneel DM; Eriksen E; Sjauw KD; van Dongen IM; Hirsch A; Packer EJ; Vis MM; Wykrzykowska JJ; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; de Mol BA; Tijssen JG; Henriques JP
    J Am Coll Cardiol; 2017 Jan; 69(3):278-287. PubMed ID: 27810347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial.
    Prondzinsky R; Unverzagt S; Russ M; Lemm H; Swyter M; Wegener N; Buerke U; Raaz U; Ebelt H; Schlitt A; Heinroth K; Haerting J; Werdan K; Buerke M
    Shock; 2012 Apr; 37(4):378-84. PubMed ID: 22266974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraaortic balloon support for myocardial infarction with cardiogenic shock.
    Thiele H; Zeymer U; Neumann FJ; Ferenc M; Olbrich HG; Hausleiter J; Richardt G; Hennersdorf M; Empen K; Fuernau G; Desch S; Eitel I; Hambrecht R; Fuhrmann J; Böhm M; Ebelt H; Schneider S; Schuler G; Werdan K;
    N Engl J Med; 2012 Oct; 367(14):1287-96. PubMed ID: 22920912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock.
    Kiehl MG; Ostermann H; Meyer J; Kienast J
    Intensive Care Med; 1997 May; 23(5):561-6. PubMed ID: 9201529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction].
    Arias EA; González-Chon O; García-López SM; Chacón MA; Noriega-Iriondo F; Vega RE; Chávez-Tapia NC
    Arch Cardiol Mex; 2005; 75(3):260-6. PubMed ID: 16294814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-NAME on coronary blood flow, infarct size and the extent of the no-reflow phenomenon.
    Pierrakos CN; Tsolakis EJ; Pozios IA; Diakos N; Charitos E; Malliaras K; Bonios MJ; Lazaris N; Papazoglou P; Venetsanakos J; Papalois A; Terrovitis JV; Nanas JN
    Int J Cardiol; 2013 Sep; 167(6):3000-5. PubMed ID: 23022088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
    Zeymer U; Bauer T; Hamm C; Zahn R; Weidinger F; Seabra-Gomes R; Hochadel M; Marco J; Gitt A
    EuroIntervention; 2011 Aug; 7(4):437-41. PubMed ID: 21764661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intervention with nitric oxide synthase inhibitors for traumatic shock in rats.
    Sun GB; Huang ZH; Sun YG; Yang WY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):306-9. PubMed ID: 12697459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-aortic balloon counterpulsation and delayed revascularization for myocardial infarction and shock in the absence of primary angioplasty: a treatment strategy with or without thrombolysis?
    Drakos SG; Anastasiou-Nana MI; Terrovitis JV; Tsagalou EP; Kanakakis J; Ntalianis A; Lazaris N; Maroulidis G; Venetsanakos J; Bonios M; Nanas JN
    Coron Artery Dis; 2008 Nov; 19(7):521-6. PubMed ID: 18923249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intra-aortic balloon pump counterpulsation in the treatment of acute myocardial infarction complicated by cardiogenic shock: Evidence from the Portuguese nationwide registry.
    Timóteo AT; Nogueira MA; Rosa SA; Belo A; Ferreira RC;
    Eur Heart J Acute Cardiovasc Care; 2016 Nov; 5(7):23-31. PubMed ID: 26373810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
    Thiele H; Schuler G; Neumann FJ; Hausleiter J; Olbrich HG; Schwarz B; Hennersdorf M; Empen K; Fuernau G; Desch S; de Waha S; Eitel I; Hambrecht R; Böhm M; Kurowski V; Lauer B; Minden HH; Figulla HR; Braun-Dullaeus RC; Strasser RH; Rochor K; Maier SK; Möllmann H; Schneider S; Ebelt H; Werdan K; Zeymer U
    Am Heart J; 2012 Jun; 163(6):938-45. PubMed ID: 22709745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.